Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Wendy Guy
FOU | Founder | 59 | 28/03/11 |
Sian Bigora
FOU | Founder | 63 | 28/03/11 |
David Young
FOU | Founder | 71 | 28/03/11 |
Patrick Lin
FOU | Founder | 58 | 28/03/11 |
George Ng
CEO | Chief Executive Officer | 49 | 07/08/23 |
Jim Stanker
DFI | Director of Finance/CFO | 67 | 04/09/18 |
Weifei Ye
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kayla Parks
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | - | |
Mary Nyberg
PRN | Corporate Officer/Principal | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
George Ng
CEO | Chief Executive Officer | 49 | 07/08/23 |
James Neal
BRD | Director/Board Member | 68 | 15/07/22 |
Justin Yorke
CHM | Chairman | 58 | 01/10/17 |
Patrick Lin
FOU | Founder | 58 | 28/03/11 |
David Young
FOU | Founder | 71 | 28/03/11 |
Director/Board Member | 66 | 10/07/22 | |
Geraldine Pannu
BRD | Director/Board Member | 54 | 12/02/20 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,863,007 | 2,512,049 ( 87.74 %) | 5,000 ( 0.1746 %) | 87.74 % |
Company contact information
Processa Pharmaceuticals, Inc.
7380 Coca Cola Drive Suite 106
21076, Hanover
+
http://www.processapharma.comSector
1st Jan change | Capi. | |
---|---|---|
+36.90% | 723B | |
+32.22% | 598B | |
-1.91% | 364B | |
+20.36% | 331B | |
+3.72% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+8.74% | 169B |